Stay updated on Ascending Dose Study of ZFN Therapeutic SB-913 in MPS II Clinical Trial
Sign up to get notified when there's something new on the Ascending Dose Study of ZFN Therapeutic SB-913 in MPS II Clinical Trial page.

Latest updates to the Ascending Dose Study of ZFN Therapeutic SB-913 in MPS II Clinical Trial page
- Check6 days agoChange DetectedThe page’s displayed revision/version number was updated from v3.5.2 to v3.5.3, reflecting a change to the site’s release rather than any study-specific information.SummaryDifference0.1%

- Check13 days agoChange DetectedRevision updated from v3.0.0? to v3.5.2 on the page. This appears to be a minor maintenance update with no impact on content or functionality.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check35 days agoChange DetectedAdded the indexing term 'Mucopolysaccharidosis, MPS-II' and removed 'Mucopolysaccharidosis type 2' from the study's terminology list.SummaryDifference0.1%

- Check42 days agoChange DetectedRevision history updated: added v3.5.0 and removed v3.4.3.SummaryDifference0.1%

- Check49 days agoChange DetectedThe displayed revision changed from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check78 days agoChange DetectedAdministrative updates: Revision: v3.4.2 was added, while Revision: v3.4.1 and a government funding/status notice were removed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Ascending Dose Study of ZFN Therapeutic SB-913 in MPS II Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ascending Dose Study of ZFN Therapeutic SB-913 in MPS II Clinical Trial page.